Visceral obesity is implicated in the development of T2DM through increased free fatty acid flux and increased triglycerides storage in other organs implicated in glucose metabolism, with secondary disturbance in insulin sensitivity, hyperinsulinemia, and beta-cell failure. The gene discussed is INS; the disease is Hyperinsulinemia.